Vaccination strategies for reducing clinical severity of coliform mastitis

Veterinary Clinics of North America - Food Animal Practice

Volumn 19, Issue 1, 2003, Pages 187-197

  Wilson, David J ^a   González, Rubén N ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIN; TOXOID;

BACTERIAL INFECTION; CLINICAL FEATURE; COLIFORM BACTERIUM; DRUG EFFICACY; DRUG SAFETY; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; MASTITIS; NONHUMAN; REVIEW; TREATMENT OUTCOME; VACCINATION; ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; FEMALE; IMMUNOLOGY; METHODOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; BACTERIAL VACCINES; CATTLE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; MASTITIS, BOVINE; VACCINATION;

EID: 2442539165     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0720(02)00070-1     Document Type: Review

References (47)

1. Hogan J., González R., Harmon R., et al. Laboratory handbook on bovine mastitis. 1999;National Mastitis Council, Madison (WI). p. 85-111
2. Carroll E. Environmental factors in bovine mastitis. J Am Vet Assoc. 170:1977;1143-1148
3. Natzke R., LeClair B. Coliform contaminated bedding and new infections. J Dairy Sci. 59:1975;2152-2154
4. Bramley A., Neave F. Studies on the control of coliform mastitis in dairy cows. Br Vet J. 131:1975;160-169
5. Eberhart R.J. Coliform mastitis. Vet Clin Food Anim. 6:1984;287-299
6. González R., Wilson D., Mohammed H., et al. A placebo-controlled trial of an Escherichia coli J5 bacterin and the ribotyping-based asessment of coliform bacteria diversity on a dairy farm. Proceedings of the 19th World Buiatrics Congress. 1996;British Cattle Veterinary Association, Edinburgh. p. 277-80
7. Jasper D., Dellinger J., Bushnell R. Herd studies on coliform mastitis. J Am Vet Med Assoc. 166:(8):1975;778-780
8. Jones G., Ward G. Cause, occurrence, and clinical signs of mastitis and anorexia in cows in a Wisconsin study. J Am Vet Med Assoc. 195:(8):1989;1108- 1113
9. Wenz J., Barrington G., Garry F., et al. Bacteremia associated with naturally occurring acute coliform mastitis in dairy cows. J Am Vet Med Assoc. 219:(7):2001;976-981
10. Wilson D., González R., Das H. Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production. J Dairy Sci. 80:(10):1997;2592-2598
11. Fuquay J., Zook A., Poe W. Metabolic and physiologic response of dairy cattle to coliform mastitis. J Dairy Sci. 58:(5):1975;751-752
12. Jackson E., Bramley J. Coliform mastitis. In Practice. 5:1983;135-146
13. Munch-Petersen E. Bovine mastitis. Survey of the literature to the end of 1935. 1938;219-233 Imperial Bureau of Animal Health, Weybridge, England
14. Anderson J.C. The problems of immunization against staphylococcal mastitis. Br Vet J. 134:1978;412-420
15. Poutrel B. Susceptibility to mastitis: a review of factors related to the cow. Ann Rech Vet. 13:1982;85-89
16. Vecht U. Immunological approach to mastitis control. Kieler Milch Forsch. 37:1985;515-523
17. Bramley A., Godinho K., Grindal R. Evidence of penetration of the bovine teat duct by Escherichia coli in the interval between milkings. J Dairy Res. 48:1981;379-386
18. Colditz I., Watson D. The immunophysiological basis for vaccinating ruminants against mastitis. Aust Vet J. 62:1985;145-153
19. Dodd F.H. Progress in mastitis control. Kieler Milch Forsch. 37:1985;216-223
20. Myllys V., Asplund K., Brofeldt E., et al. Bovine mastitis in Finland in 1988 and 1995 - changes in prevalence and antimicrobial resistance. Acta Vet Scand. 39:(1):1998;119-126
21. Myllys V., Honkanen-Buzalski P., Huovinen M., et al. Association of changes in the bacterial ecology of bovine mastitis with changes in the use of milking machines and antibacterial drugs. Acta Vet Scand. 35:(4):1994;363-369
22. Beaudeau F., Fourichon C., Seegers H., et al. Risk of clinical mastitis in dairy herds with a high proportion of low individual milk somatic-cell counts. Prev Vet Med. 53:(1-2):2002;43-54
23. Green M., Green L., Cripps P. Low bulk milk somatic cell counts and toxic mastitis: an association. Proceedings of the 19th World Buiatrics Congress. 1996;British Cattle Veterinary Association, Edinburgh. p. 312-5
24. Wilson M. The influence of preparturient intramammary vaccination on bovine mammary secretions. Immunology. 23:1972;947-955
25. Wilson M., Duncan J., Heistand F., et al. The influence of preparturient intramammary vaccination on immunoglobulin levels in bovine mammary secretions. Immunology. 23:1972;313-320
26. Rainard P. Experimental mastitis with Escherichia coli: sequential response of leukocytes and opsonic activity in milk of immunized and unimmunized cows. Ann Rech Vet. 14:1983;281-286
27. Rainard P., Caffin J. Sequential changes in serum albumin, immunoglobulin (IgG1, IgG2, IgM) and lactoferrin concentrations in milk following infusion of Escherichia coli into the udder of immunized and unimmunized cows. Ann Rech Vet. 14:1983;271-279
28. Smith K. Mastitis control: a discussion. J Dairy Sci. 66:1983;1790-1794
29. Braude A., Ziegler E., Douglas H., et al. Antibody to cell wall glycolipid of gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. J Infect Dis. 136:1977;S167-S172
30. Nells M., Niswander C. Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Infect Immun. 46:1984;677-681
31. Oishi K., Koles N., Guelde G., et al. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J Infect Dis. 165:1992;34-45
32. Pluschke G., Mayden J., Achtman M., et al. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Infect Immun. 42:1983;907-913
33. Sakulramrung R., Domingue G. Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5. J Infect Dis. 151:(6):1985;995-1004
34. Tyler J., Cullor J., Osburn B., et al. Relationship between serological recognition of Escherichia coli O111:B4 (J5) and clinical coliform mastitis in cattle. Am J Vet Res. 49:1988;1950-1954
35. Dosogne H., Vangroenweghe F., Burvenich C. Potential mechanism of action of J5 vaccine in protection against severe bovine coliform mastitis. Vet Res. 33:2002;1-12
36. Tyler J., Spears H., Nelson R. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5). J Dairy Sci. 75:(7):1992;1821-1825
37. Baumgartner J., Heumann D., Calandra T., et al. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5. J Infect Dis. 163:(4):1991;769-772
38. Sprouse R., Garner H., Lager K. Cross-protection of calves from E. coli and P. multocida endotoxin challenges via S. typhimurium mutant bacterin-toxoid. Agri Pract. 11:(2):1990;29-34
39. González R., Cullor J., Jasper D., et al. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. Can J Vet Res. 53:(3):1989;301-305
40. Cullor J.S. The Escherichia coli J5 vaccine: investigating a new tool to combat mastitis. Vet Med. 86:(8):1991;836-844
41. Hogan J., Todhunter D., Tomita G., et al. Field trial to determine efficacy of an Escherichia coli J5 vaccine on mammary health. J Dairy Sci. 74:(Suppl 1):1991;169
42. McClure A., Christopher E., Wolff W., et al. Effect of Re-17 mutant Salmonella typhimurium bacterin toxoid on clinical coliform mastitis. J Dairy Sci. 77:(8):1994;2272-2280
43. Scott H., Sargeant J., Ireland M., et al. Efficacy of an Re-17 mutant Salmonella typhimurium core antigen vaccine under field conditions. Proceedings of the 19th World Buiatrics Congress. 1996;British Cattle Veterinary Association, Edinburgh. p. 281-4
44. Musser J., Anderson K. Effect of vaccination with an Escherichia coli bacterin-toxoid on milk production in dairy cattle. J Am Vet Med Assoc. 209:(7):1996;1291-1293
45. DeGraves F., Fetrow J. Partial budget analysis of vaccinating dairy cattle against coliform mastitis with an Escherichia coli J5 vaccine. J Am Vet Med Assoc. 199:(4):1991;451-455
46. White M., Glickman L., Montgomery M., et al. Analysis of the clinical findings used to diagnose coliform mastitis in dairy cows, and comparison to a prediction model. Cornell Vet. 77:1987;13-20
47. Tomita G., Nickerson S., Owens W., et al. Influence of route of vaccine administration against experimental intramammary infection caused by Escherichia coli. J Dairy Sci. 81:(8):1998;2159-2164